Saturday, October 3, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· December 12, 2025

Stock market today: Dow, S&P 500, Nasdaq sink amid tech exodus on Wall Street

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq sink amid tech exodus on Wall Street US stocks turned sharply lower on Friday, with the Nasdaq leading the way lower amid a broader rotation from tech to value names…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Gold is on pace for its best year since 1979, having surpassed its all-time high more than 50 times in 2025

    80% confidence

  • Goolsbee remains optimistic that rates can come down a significant amount over the next year

    80% confidence

  • AI and economic growth will fuel a 12% earnings jump

    80% confidence

  • Goolsbee voted against the December rate cut, preferring to wait for more inflation data before another cut

    80% confidence

  • The US dollar will weaken in 2026 as the Fed continues rate cuts; consensus forecasts the dollar index will weaken ~3% by end of 2026

    80% confidence

  • The US dollar will resume its slide in 2026 as the Federal Reserve continues to ease monetary policy while other central banks hold steady or move toward raising rates

    80% confidence

  • Lululemon is encouraged by early holiday season performance and continues to make progress in its turnaround plan, expecting more results in 2026

    80% confidence

  • Rivian's Autonomy & AI Day increased confidence in RIVN's positioning as software and AI-defined vehicles increasingly become industry table stakes

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com